|

Chemotherapy of Physician's Choice Clinical Trials

1 actively recruiting trial

Also known as: Capecitabine, Eribulin, Gemcitabine, Vinorelbine, nab-paclitaxel

Pipeline

Phase 2: 1

Top Sponsors

  • Cancer Institute and Hospital, Chinese Academy of Medical Sciences1

Indications

  • HER2-Low Unresectable/Metastatic Breast Cancer Complicated With Visceral Crisis1
  • Breast Cancer1
  • Cancer1

Other1 trial

The Efficacy and Safety of Trastuzumab Rezetecan (SHR-A1811) in HER2-Low Unresectable/Metastatic Breast Cancer Patients With Visceral Crisis
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.